Answer

Introduction

The growing availability of semaglutide-based drugs like Ozempic signals a shift where medical solutions reshape not just health but social expectations, raising ethical concerns about body image, autonomy, and evolving societal norms.

Body

Ethical implications on Body Image, Individual Autonomy and Societal Norms

• Thinness as the new norm: Easier weight loss shifts thinness from aspiration to expectation, making it a baseline standard.
• Shrinking body diversity: Standardisation reduces acceptance and visibility of diverse body types.
  Eg: Fashion systems may narrow size ranges and silhouettes.
• Deepening appearance-based bias: Physical appearance increasingly shapes opportunities and social outcomes.
  Eg: Role of body image in jobs and matrimonial preferences.
• Medicalisation of lifestyle: Medical drugs increasingly used for cosmetic enhancement over treatment.
  Eg: Ozempic used beyond diabetes for weight loss.
• Rising comparison pressure: Non-users face subtle judgement due to visible differences.
• Constrained choice: Easier access reduces genuine freedom to opt out of transformation despite no legal compulsion.
• Unequal access and conformity: Affordability determines who can meet emerging standards.
• Diluted informed consent: Non-medical usage may overlook risks and side effects.
  Eg: Transition from therapeutic to lifestyle use.
• Shift in cultural values: Effort-based ideals replaced by quick, medical transformation.
  Eg: Thinness earlier linked to discipline can now be medically achieved.

Way Forward

• Strengthen regulatory oversight on usage: Ensure drugs are prescribed strictly for medical conditions, not cosmetic use.
  Eg: Central Drugs Standard Control Organization guidelines on prescription-only medicines.
• Promote body positivity and diversity norms: Public campaigns to normalise diverse body types and reduce stigma.
  Eg: Ministry of Health and Family Welfare awareness campaigns on healthy lifestyles, not appearance.
• Ensure ethical medical practice and informed consent: Doctors must clearly communicate risks and discourage misuse.
  Eg: Medical Council guidelines on ethical prescription practices.
• Improve equitable access and prevent inequality: Regulate pricing and prevent elite capture of such technologies.
  Eg: Generic drug policies in India improving affordability of essential medicines.
• Encourage holistic health approaches over quick fixes: Emphasise diet, exercise, and mental well-being alongside medical treatment.
  Eg: Fit India Movement promoting lifestyle-based health. 

Conclusion

While semaglutide-based drugs offer health benefits, their widespread use risks reshaping social norms in ways that undermine autonomy and diversity. Ethical governance must prioritise informed choice, inclusivity, and prevent coercive standardisation of bodies.

DOWNLOAD PDF